BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10548583)

  • 1. Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein.
    Abrams JT; Vonderheid EC; Kolbe S; Appelt DM; Arking EJ; Balin BJ
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):895-905. PubMed ID: 10548583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Sézary T cell-activating factor, Chlamydia pneumoniae, and cutaneous T cell lymphoma.
    Abrams JT; Balin BJ; Vonderheid EC
    Ann N Y Acad Sci; 2001 Sep; 941():69-85. PubMed ID: 11594584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells.
    Döbbeling U; Dummer R; Laine E; Potoczna N; Qin JZ; Burg G
    Blood; 1998 Jul; 92(1):252-8. PubMed ID: 9639524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Chlamydia pneumoniae-specific antibodies binding to the VD2 and VD3 regions of the major outer membrane protein.
    Klein M; Kötz A; Bernardo K; Krönke M
    J Clin Microbiol; 2003 May; 41(5):1957-62. PubMed ID: 12734234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK
    G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
    Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
    J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
    Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous T-cell lymphoma: a review.
    Winkler CF; Bunn PA
    Crit Rev Oncol Hematol; 1983; 1(1):49-92. PubMed ID: 6083835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of Epstein-Barr virus in cutaneous lesions of mycosis fungoides and Sézary syndrome.
    Dreno B; Celerier P; Fleischmann M; Bureau B; Litoux P
    Acta Derm Venereol; 1994 Sep; 74(5):355-7. PubMed ID: 7817670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential relevance of Chlamydia pneumoniae surface proteins to an effective vaccine.
    Christiansen G; Pedersen AS; Hjerno K; Vandahl B; Birkelund S
    J Infect Dis; 2000 Jun; 181 Suppl 3():S528-37. PubMed ID: 10839754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas.
    Bodetti TJ; Timms P
    Infect Immun; 2000 May; 68(5):2744-7. PubMed ID: 10768968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma.
    Schlapbach C; Ochsenbein A; Kaelin U; Hassan AS; Hunger RE; Yawalkar N
    J Am Acad Dermatol; 2010 Jun; 62(6):995-1004. PubMed ID: 20466174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020.
    Bobrowicz M; Fassnacht C; Ignatova D; Chang YT; Dimitriou F; Guenova E
    Int Arch Allergy Immunol; 2020; 181(10):733-745. PubMed ID: 32690848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Leroy S; Dubois S; Tenaud I; Chebassier N; Godard A; Jacques Y; Dréno B
    Br J Dermatol; 2001 May; 144(5):1016-23. PubMed ID: 11359391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological detection of cutaneous T-cell lymphoma-associated antigens.
    Eichmuller S; Usener D; Dummer R; Stein A; Thiel D; Schadendorf D
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):629-34. PubMed ID: 11149944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous T cell lymphomas: photochemotherapy immunomodulation with analysis of the inflammatory-expansive cellular dynamic.
    Werber-Bandeira L; Herdy AM; Pagani EA; Filgueira AL
    Dermatol Ther; 2014; 27(2):74-8. PubMed ID: 24703262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
    Edelson RL
    J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.